Drug
TQ05105
TQ05105 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
completed240%
not_yet_recruiting120%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingphase_1
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects
NCT07480824
completedphase_1
A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects
NCT07293390
completedphase_1
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
NCT06598956
unknownphase_1
A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH）
NCT04326348
unknownphase_1
A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms
NCT04339400
Clinical Trials (5)
Showing 5 of 5 trials
NCT07480824Phase 1
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects
NCT07293390Phase 1
A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects
NCT06598956Phase 1
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
NCT04326348Phase 1
A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH）
NCT04339400Phase 1
A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5